title: SGLT-2 INHIBITORS AS ADJUNCT THERAPY IN TYPE 1 DIABETES: REASON FOR HOPE AND CAUTION.
authors.forename: Wendy
authors.initials: W
authors.lastname: Lane
mesh_terms: D001786:Blood Glucose / Q000187:drug effects*; D000068896:Canagliflozin / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D001786:Blood Glucose; D000068896:Canagliflozin